• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study.

作者信息

Durand Christine M, Barnaba Brittany, Yu Sile, Brown Diane M, Chattergoon Michael A, Bair Nichole, Naqvi Fizza F, Sulkowski Mark, Segev Dorry L, Desai Niraj M

机构信息

Johns Hopkins University School of Medicine, Baltimore, Maryland (C.M.D., B.B., S.Y., D.M.B., M.A.C., N.B., F.F.N., M.S., D.L.S., N.M.D.).

出版信息

Ann Intern Med. 2021 Jan;174(1):137-138. doi: 10.7326/M20-1468. Epub 2020 Sep 8.

DOI:10.7326/M20-1468
PMID:32894697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8288461/
Abstract
摘要

相似文献

1
Four-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Hepatitis C-Viremic Donors to Hepatitis C-Negative Recipients: An Open-Label Nonrandomized Study.针对丙型肝炎病毒血症供体至丙型肝炎病毒阴性受体的肾移植受者进行的四周直接抗病毒预防：一项开放标签非随机研究。
Ann Intern Med. 2021 Jan;174(1):137-138. doi: 10.7326/M20-1468. Epub 2020 Sep 8.
2
A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.丙型肝炎病毒血症供体至丙型肝炎病毒阴性受体的肾移植综述。
Kidney Int. 2021 Dec;100(6):1190-1198. doi: 10.1016/j.kint.2021.06.034. Epub 2021 Jul 6.
3
Re: Ultra-Short Duration Direct Acting Antiviral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients.关于：超短疗程直接作用抗病毒药物预防措施以防止丙型肝炎病毒血症供体将病毒传播给丙型肝炎阴性肾移植受者。
J Urol. 2020 Oct;204(4):868. doi: 10.1097/JU.0000000000001214. Epub 2020 Jul 23.
4
Transplantation of kidneys from HCV viremic donors to HCV viremic recipients followed by early direct acting antiviral therapy without ribavirin.将丙型肝炎病毒血症供体的肾脏移植给丙型肝炎病毒血症受体，随后进行无利巴韦林的早期直接抗病毒治疗。
J Viral Hepat. 2019 Mar;26(3):407-409. doi: 10.1111/jvh.13042. Epub 2019 Jan 22.
5
Two-Week Direct-Acting Antiviral Prophylaxis for Kidney Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia: A Small Uncontrolled Trial.针对从丙型肝炎病毒血症供体到无丙型肝炎病毒血症受体的肾移植受者进行为期两周的直接抗病毒预防：一项小型非对照试验。
Ann Intern Med. 2023 Dec;176(12):1682-1684. doi: 10.7326/M23-2682. Epub 2023 Nov 28.
6
Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation.丙型肝炎病毒血症供者的肝、肾受者选择：2019 年移植争议会议的共识报告
Transplantation. 2020 Mar;104(3):476-481. doi: 10.1097/TP.0000000000003014.
7
Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.将来自丙型肝炎病毒血症供体的肾脏移植给丙型肝炎病毒阴性受体后，基于索磷布韦的抗病毒治疗早期成功。
Transpl Infect Dis. 2019 Oct;21(5):e13146. doi: 10.1111/tid.13146. Epub 2019 Jul 31.
8
Re: Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-Positive Recipients in the Direct-Acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?关于：在直接抗病毒药物时代，供体丙型肝炎病毒对丙型肝炎病毒阳性受者肾移植结局的影响：是时候修订肾脏供体风险指数了吗？
J Urol. 2020 Dec;204(6):1369. doi: 10.1097/JU.0000000000001277. Epub 2020 Sep 21.
9
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.丙型肝炎病毒核酸检测阳性的实体器官移植物移植到丙型肝炎病毒阴性受者：真实世界的经验。
Hepatology. 2020 Jul;72(1):32-41. doi: 10.1002/hep.31011. Epub 2020 Apr 15.
10
Detection of Hepatitis C Antibodies Without Viral Transmission in Hepatitis C-Negative Recipients Receiving Kidneys From Hepatitis C-Positive Donors Treated With Direct-Acting Antiviral Therapy.在接受接受直接抗病毒治疗的丙型肝炎病毒阳性供体肾脏的丙型肝炎病毒阴性受者中检测无病毒传播的丙型肝炎抗体
Transplantation. 2018 Mar;102(3):e121-e122. doi: 10.1097/TP.0000000000002034.

引用本文的文献

1
Prophylactic Treatment of Hepatitis C Virus Infection After Kidney Transplantation with the Combination of Glecaprevir/Pibrentasvir and Sofosbuvir in a Highly Sensitized Hepatitis C Virus-Negative Recipient: A Case Report and Review of the Literature.在高度致敏的丙型肝炎病毒阴性肾移植受者中联合使用glecaprevir/pibrentasvir和索磷布韦对肾移植后丙型肝炎病毒感染进行预防性治疗：一例病例报告及文献综述
Biomedicines. 2025 Feb 14;13(2):472. doi: 10.3390/biomedicines13020472.
2
Prophylactic 2-week glecaprevir/pibrentasvir in hepatitis C positive-to-negative kidney transplantation.丙型肝炎阳性转为阴性的肾移植患者预防性使用2周的格卡瑞韦/哌仑他韦。
Nephrol Dial Transplant. 2025 Jun 30;40(7):1322-1331. doi: 10.1093/ndt/gfae271.
3
Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients.丙型肝炎病毒血症死亡供者向非病毒血症受者进行肾移植的 12 个月的肾脏和肝脏结局。
Transpl Infect Dis. 2024 Feb;26(1):e14213. doi: 10.1111/tid.14213. Epub 2023 Dec 19.
4
Management of Hepatitis C Virus and Hepatitis B Virus Infection in the Setting of Kidney Disease.肾脏疾病患者丙型肝炎病毒和乙型肝炎病毒感染的管理。
Adv Kidney Dis Health. 2023 Jul;30(4):343-355. doi: 10.1053/j.akdh.2023.04.003.
5
Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response.来自丙型肝炎供体的肺移植中进行抢先抗病毒治疗可导致快速且持续的病毒学应答。
JTCVS Open. 2023 Mar 10;14:602-614. doi: 10.1016/j.xjon.2023.02.014. eCollection 2023 Jun.
6
Acute hepatitis C virus infection: clinical update and remaining challenges.急性丙型肝炎病毒感染：临床最新进展和尚存挑战。
Clin Mol Hepatol. 2023 Jul;29(3):623-642. doi: 10.3350/cmh.2022.0349. Epub 2023 Feb 20.
7
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5.泛基因型直接作用抗病毒药物治疗慢性肾脏病 4 或 5 期合并丙型肝炎病毒感染患者。
Hepatol Int. 2022 Oct;16(5):1001-1019. doi: 10.1007/s12072-022-10390-z. Epub 2022 Jul 25.
8
Efficacy and Safety of Direct-Acting Antivirals in Kidney Transplantation From HCV-Viremic Donors to Negative Recipients: A Meta-Analysis.直接作用抗病毒药物在丙型肝炎病毒血症供体至阴性受体肾移植中的疗效与安全性：一项荟萃分析
Front Med (Lausanne). 2022 May 18;9:802686. doi: 10.3389/fmed.2022.802686. eCollection 2022.
9
Liver Outcome in Renal Transplant Recipients Who Acquired Hepatitis C Infection From an Infected Graft: Study Based on Liver Biopsy Findings.肾移植受者从受感染移植物获得丙型肝炎感染后的肝脏转归：基于肝活检结果的研究
Transplant Direct. 2022 May 26;8(6):e1342. doi: 10.1097/TXD.0000000000001342. eCollection 2022 Jun.
10
Kidney Transplantation From Hepatitis-C Viraemic Donors:Considerations for Practice in the United Kingdom.从丙型肝炎病毒血症供体进行肾移植：英国的实践考虑因素。
Transpl Int. 2022 May 3;35:10277. doi: 10.3389/ti.2022.10277. eCollection 2022.

本文引用的文献

1
Preemptive Treatment With Elbasvir and Grazoprevir for Hepatitis C-Viremic Donor to Uninfected Recipient Kidney Transplantation.使用艾尔巴韦和格拉瑞韦对丙型肝炎病毒血症供体至未感染受体的肾移植进行抢先治疗。
Kidney Int Rep. 2020 Jan 13;5(4):459-467. doi: 10.1016/j.ekir.2020.01.001. eCollection 2020 Apr.
2
Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.丙型肝炎病毒核酸检测阳性的实体器官移植物移植到丙型肝炎病毒阴性受者：真实世界的经验。
Hepatology. 2020 Jul;72(1):32-41. doi: 10.1002/hep.31011. Epub 2020 Apr 15.
3
Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients.超短疗程直接作用抗病毒预防治疗，以预防丙型肝炎病毒血症供者向丙型肝炎阴性肾移植受者的病毒传播。
Am J Transplant. 2020 Mar;20(3):739-751. doi: 10.1111/ajt.15664. Epub 2019 Nov 15.
4
Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.肝纤维化性胆汁淤积性肝炎在 HCV 病毒血症供者至 HCV 阴性受者的肾移植后发生：DAA 时代的一个独特并发症。
Am J Transplant. 2020 Feb;20(2):600-605. doi: 10.1111/ajt.15583. Epub 2019 Sep 18.
5
Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.从丙型肝炎感染供体向丙型肝炎阴性受者移植肾脏：单中心经验。
Am J Transplant. 2019 Nov;19(11):3046-3057. doi: 10.1111/ajt.15530. Epub 2019 Aug 2.
6
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.HCV 感染供体的心肺移植到未感染受者。
N Engl J Med. 2019 Apr 25;380(17):1606-1617. doi: 10.1056/NEJMoa1812406. Epub 2019 Apr 3.
7
Risks, benefits, and ethical questions associated with transplanting kidneys from hepatitis C virus-infected donors into hepatitis C virus-negative patients.将丙型肝炎病毒感染供体的肾脏移植给丙型肝炎病毒阴性患者所涉及的风险、益处及伦理问题。
Semin Dial. 2019 Mar;32(2):179-186. doi: 10.1111/sdi.12767. Epub 2018 Nov 26.
8
Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.直接作用抗病毒预防在丙型肝炎病毒感染供体向非感染受者的肾移植中的应用：一项开放标签非随机试验。
Ann Intern Med. 2018 Apr 17;168(8):533-540. doi: 10.7326/M17-2871. Epub 2018 Mar 6.
9
Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients.将丙型肝炎病毒感染的肾脏移植给未感染受者的试验。
N Engl J Med. 2017 Jun 15;376(24):2394-2395. doi: 10.1056/NEJMc1705221. Epub 2017 Apr 30.